Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.

	Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.
	Yin, Rutie ; Li, Ning ; Wu, Lingying ; Wang, Jing ; Zhu, Jianqing ; Pan, Lingya ; Kong, Beihua ; Zheng, Hong ; Liu, Jihong ; Wu, Xiaohua
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2022-06-01
卷号	40
ISSN号	0732-183X
资助项目	Zai Lab (Shanghai) Co. Ltd. ; National Major Scientific and Technological Special Project for Significant New Drugs Development in 2020, China[2020ZX09101-014]
WOS研究方向	Oncology
语种	英语
出版者	LIPPINCOTT WILLIAMS & WILKINS
WOS记录号	WOS:000863680301608
资助机构	Zai Lab (Shanghai) Co. Ltd. ; National Major Scientific and Technological Special Project for Significant New Drugs Development in 2020, China
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/129905]
专题	中国科学院合肥物质科学研究院
作者单位	1.Chongqing Univ, Gynecol Oncol Ctr, Canc Hosp, Chongqing, Peoples R China 2.Sichuan Univ, Dept Gynecol & Obstet, Chengdu, Peoples R China 3.Sichuan Univ, West China Second Univ Hosp, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, Chengdu, Peoples R China 4.Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China 5.Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China 6.Hunan Canc Hosp, Changsha, Peoples R China 7.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 8.Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing, Peoples R China 9.Shandong Univ, Qilu Hosp, Jinan, Peoples R China 10.Peking Univ Canc Hosp & Inst, Dept Gynecol Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China
推荐引用方式 GB/T 7714	Yin, Rutie,Li, Ning,Wu, Lingying,et al. Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40.
APA	Yin, Rutie.,Li, Ning.,Wu, Lingying.,Wang, Jing.,Zhu, Jianqing.,...&Hou, Jianmei.(2022).Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy..JOURNAL OF CLINICAL ONCOLOGY,40.
MLA	Yin, Rutie,et al."Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.".JOURNAL OF CLINICAL ONCOLOGY 40(2022).